Summary & Overview
HCPCS G9410: CIED Infection Requiring Device Removal or Surgical Revision
HCPCS Level II code G9410 denotes inpatient or procedural care for patients admitted within 180 days after cardiac implantable electronic device (CIED) implantation, replacement, or revision who develop an infection requiring device removal or surgical revision. Nationally, this code flags clinically significant postoperative infections that drive resource use, inpatient procedures, and coordination across surgical and infectious disease teams. It is relevant to hospital billing, quality measurement, and post-procedural surveillance.
Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical scenario this code captures, typical sites of service, and the operational implications for inpatient and procedural billing. The publication provides benchmarks where available, discusses policy and coverage considerations affecting payment and authorization, and explains how G9410 is used in claims to denote device-related infections requiring operative management. This summary is intended for coding professionals, billing managers, revenue cycle stakeholders, and clinicians involved in perioperative care and device management.
Billing Code Overview
HCPCS Level II code G9410 describes a patient admitted within 180 days who is status post cardiac implantable electronic device (CIED) implantation, replacement, or revision and who has an infection that requires device removal or surgical revision. This code represents care tied to a postoperative infectious complication of a CIED that necessitates operative management.
-
Service type: Surgical management related to CIED infection, including device removal or revision
-
Typical site of service: Inpatient hospital or same-day surgical facility where device explantation, revision, or related operative procedures are performed
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with ischemic cardiomyopathy who underwent cardiac implantable electronic device (CIED) implantation two months earlier presents to the emergency department with fever, erythema and purulent drainage at the device pocket site and systemic signs of infection. Blood cultures are positive for Staphylococcus aureus. The patient is admitted and evaluated by cardiology and cardiothoracic surgery. Imaging and device interrogation suggest pocket infection and possible lead involvement. The clinical workflow includes initial stabilization, targeted intravenous antibiotics, documentation of informed consent for device extraction, scheduling of transvenous lead and generator removal in the operating room or electrophysiology lab under monitored anesthesia care or general anesthesia, and coordination of temporary pacing support if needed. After device removal, cultures are obtained from the pocket and leads; the wound is managed with primary closure or delayed closure depending on contamination; plans for reimplantation are deferred until infection is cleared, typically after a course of antibiotics and negative blood cultures. Discharge planning includes outpatient infectious disease follow-up and documentation of device removal and infection-related diagnosis codes for billing under G9410.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typically required (e.g., complex extraction with extensive adhesions). |